CFM
TWST icon

Catalyst Funds Management’s Twist Bioscience TWST Stock Holding History

Catalyst Funds Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,488
Closed -$326K – 1607
2024
Q1 		$326K Buy
+9,488
New +$342K 0.09% 178

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Catalyst Funds Management's TWST Position: Q2 2024 in Review

Catalyst Funds Management sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 9,488 shares — an estimated $326K sold.

Catalyst Funds Management first reported a position in TWST in Q1 2024 and held it in 1 quarter. The position peaked at $326K in Q1 2024. 262 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • Catalyst Funds Management reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 9,488 Twist Bioscience shares in Q2 2024, an estimated $326K.
  • Catalyst Funds Management first reported a position in Twist Bioscience in Q1 2024 and held it in 1 quarter.
  • Catalyst Funds Management's Twist Bioscience position peaked at $326K in Q1 2024.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Catalyst Funds Management's 13F filing for Q2 2024, filed 18 Dec 2024.